Hitachi Medical Systems Europe introduces "LISENDO 880", the new premium 2D/4D Cardiovascular Ultrasound System, featuring HDAnalyticsTM by Hitachi at EuroEcho Imaging 2017 (PHOTO)

Zug (ots) -

- Indication: Picture can be downloaded free of charge under:
http://www.presseportal.ch/de/nr/100012989?langid=2 -

Premium cardiac and vascular imaging rises to a new standard as
Hitachi Medical Systems Europe introduces its new premium 2D/4D
cardiovascular ultrasound system, the LISENDO 880, featuring
HDAnalyticsTM, a unique and accurate cardiovascular analysis package
for confident cardiac hemodynamic assessments, at EuroEcho Imaging
2017 in Lisbon, Portugal, December 6, 2017.

Since their inception, today's ultrasound systems have progressed
to become essential medical devices for all levels of cardiovascular
care. The LISENDO 880 is Hitachi's new premium 2D/4D diagnostic
ultrasound solution for cardiologists that redefines the vision of
cardiac ultrasound by providing exceptional clinical performance
coupled with state-of-the-art features and analytics.

Hitachi released the world's first diagnostic ultrasound system in
1960 and the world's first Colour Doppler ultrasound system in 1983.
Continuing this history of innovation, Hitachi introduced Vector Flow
Mapping (VFM) analysis using ultrasound in 2013. Hitachi stands out
as a company dedicated to providing unique solutions to
echocardiography's clinical challenges. The LISENDO 880 maintains
Hitachi's tradition of providing exceptionally innovative ultrasound
for cardiovascular care.

The LISENDO 880 was developed to address the most important needs
for cardiovascular imaging:

Pure Image Technology

The advanced architecture of the LISENDO 880 offers
state-of-the-art transducer technology for 2D/4D imaging, a high
performance OLED display, premium image optimization parameters such
as eFocusing and Pure Symphonic Architecture to capture the subtlest
of changes and produce the highest-quality 'sound'.

Seamless Workflow

The LISENDO 880 was designed to provide maximum scanning comfort,
along with state-of-the-art technology to help you complete your
exams more easily. LISENDO's flexible positioning which includes a
four-point articulating monitor arm and adjustable panel height,
supports comfortable operation while the operation panel allows
ergonomic function adjustment as a part of our intuitive user
interface. LISENDO 880 delivers seamless workflow users expect in a
premium ultrasound system.

Additionally, LISENDO 880 is equipped with a sophisticated
automatic anatomy recognition and cardiac function measurement
package based on our HDSI (HemoDynamic Structural Intelligence).
Smart cardiac measurements, using learning data structured by
Hitachi's big data and Artificial Intelligence (AI) technology
significantly improve the examination efficiency and create new value
with Hitachi's unique solutions.

Your Application

The LISENDO 880 is Hitachi's most advanced ultrasound system
offering premium 2D/4D cardiovascular applications and innovative
cardiac imaging features, namely the unique HDAnalytics(TM)
(HemoDynamic Analytics) package which includes LVeFlow, iDGD (Dual
Gate Doppler) with R-R Navigation, VFM (Vector Flow Mapping) and
eTRACKING with Wave Intensity. In addition, LISENDO 880 offers the
Eyeball EF and i2DTT quantification tools.

With these features, LISENDO 880 moves cardiac evaluations to a
new level and maintains Hitachi's tradition of providing
exceptionally innovative ultrasound for cardiovascular care.

About Hitachi Medical Systems Europe

Hitachi Healthcare in Europe is represented by Hitachi Medical
Systems Europe Holding AG, Zug, Switzerland. The company is a first
choice supplier of open and powerful high-field MRI systems,
multi-slice CT systems as well as medical ultrasound, endoscopic and
optical topography systems (NIRS). Ultrasound expertise encompasses
clinical applications such as cardiology, radiology, internal
medicine, obstetrics/gynecology, gastroenterology, urology and
surgery. Hitachi Medical Systems Europe offers a complete range of
solutions to address a wide range of medical challenges. For more
information about Hitachi Medical Systems Europe Holding AG,

For more information, please visit
http://www.hitachi-medical-systems.eu

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers
innovations that answer society's challenges. The company's
consolidated revenues for fiscal 2016 (ended March 31, 2017) totaled
9,162.2 billion yen ($81.8 billion). The Hitachi Group is a global
leader in the Social Innovation Business, and it has approximately
304,000 employees worldwide. Through collaborative creation, Hitachi
is providing solutions to customers in a broad range of sectors,
including Power / Energy, Industry / Distribution / Water, Urban
Development, and Finance / Government & Public / Healthcare.

For more information on Hitachi, please visit the company's
website at http://www.hitachi.com.

Pressekontakt:
Romea Wallnoefer
Hitachi Medical Systems Europe Holding AG
r.wallnoefer@hitachi-medical-systems.com
+41 41 748 63 33

Original-Content von: Hitachi Medical Systems Europe Holding AG, übermittelt durch news aktuell